37 results on '"Noventa, Franco"'
Search Results
2. Dealing with high-risk AL Amyloidosis patients: a single hematologic Center Experience.
3. Impact if HBV infection in HCV/HBV coinfected patients treated with DAAs in north Italy
4. COVID-19 and Venous Thromboembolism in Intensive Care or Medical Ward
5. Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure
6. Determinants of severe post-thrombotic syndrome: The role of thrombus location
7. THU-141-Efficacy and safety of elbasvir/grazoprevir in a large real-life cohort of HCV-infected patients
8. THU-128-Renal safety in 3,264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study
9. SAT-262-Long-term liver function outcome and related risk factors in HCV cirrhotic patients treated with direct-acting antiviral therapy: Results from the Navigatore platform in Veneto-Italy
10. THU-166-Treatment of 320 genotype 3 cirrhotic patients with 12 weeks of sofosbuvir/velpatasvir with or without ribavirin: Real life experience from Italy
11. THU-131-Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir for retreatment of chronic hepatitis C patients with a previous failure to direct-acting antivirals: A real-life study from the NAVIGATORE Lombardia and Veneto Networks
12. THU-180-Treatment of genotype 3 HCV infection in the large real-life “Navigatore Lombardia” multicentre cohort: Results from three different regimens
13. Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C
14. Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study
15. An association between residual vein thrombosis and subclinical atherosclerosis: Cross-sectional study
16. Does the presence of clinical symptoms of pulmonary embolism affect the outcome of patients with deep vein thrombosis?
17. Recanalization rate in patients with proximal vein thrombosis treated with the direct oral anticoagulants
18. ECG parameters predict left ventricular conduction delay in patients with left ventricular dysfunction
19. Optimization of left ventricular pacing site plus multipoint pacing improves remodeling and clinical response to cardiac resynchronization therapy at 1 year
20. Post-thrombotic syndrome and the risk of subsequent recurrent thromboembolism
21. ACUTE OPTIMIZATION OF LEFT VENTRICULAR PACING SITE PLUS MULTIPOINT PACING IMPROVE REMODELING AND CLINICAL RESPONSE OF CRT AT ONE YEAR FOLLOW UP
22. Residual vein thrombosis and the risk of subsequent serious complications
23. Multipoint pacing by a left ventricular quadripolar lead improves the acute hemodynamic response to CRT compared with conventional biventricular pacing at any site
24. Role of aneurysm sac embolization during endovascular aneurysm repair in the prevention of type II endoleak-related complications
25. PS8. Role of Intraoperative Aneurysm Sac Embolization during EVAR in the Prevention of Type II Endoleak
26. Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: Results of a multicenter, large-scale study
27. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C
28. Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases
29. Simultaneous surgical treatment of abdominal aortic aneurysm and carcinoma of the bladder
30. Association of the G20210A mutation in the factor II gene with systemic embolism in nonvalvular atrial fibrillation
31. High levels of soluble tumor necrosis factor superfamily receptors in patients with hepatitis C virus infection and lymphoproliferative disorders
32. Two PKR inhibitor HCV proteins correlate with early but not sustained response to interferon
33. Outcome of chronic hepatitis B in Caucasian children during a 20-year observation period
34. Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation∗∗The investigators and institutions participating in the study are listed in the Appendix.
35. Immunosuppressive therapy prevents recurrent pericarditis
36. Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices
37. Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.